TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32000750

Group type: EXPERIMENTAL
Intervention: Unhealthy diet
Number of subjects: 8749

Group type: EXPERIMENTAL
Intervention: Low physical activity
Number of subjects: 8749

Group type: EXPERIMENTAL
Intervention: Hypertension
Number of subjects: 8749

Group type: EXPERIMENTAL
Intervention: Obesity
Number of subjects: 8749

Group type: EXPERIMENTAL
Intervention: Diabetes mellitus
Number of subjects: 8749

Group type: EXPERIMENTAL
Intervention: Hypercholesterolemia
Number of subjects: 8749

Group type: EXPERIMENTAL
Intervention: Consumption of recommended vegetable servings
Number of subjects: 8749

Group type: EXPERIMENTAL
Intervention: Fish consumption
Number of subjects: 8749

Group type: EXPERIMENTAL
Intervention: No risk factors for CVD
Number of subjects: 8749

Group type: EXPERIMENTAL
Intervention: Multiple risk factors for CVD
Number of subjects: 8749

Group type: EXPERIMENTAL
Intervention: Geographic variations in risk factors
Number of subjects: 8749
Study: 33630393

Group type: EXPERIMENTAL
Intervention: Tranexamic acid (1 g)
Number of subjects: 192

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 192
Study: 32810921

Group type: EXPERIMENTAL
Intervention: Digital cognitive behavioural therapy for insomnia (Sleepio)
Number of subjects: 3352
Study: 36200936

Group type: EXPERIMENTAL
Intervention: Alendronate
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Teriparatide
Number of subjects: 141

Group type: COMPARATOR
Intervention: Control (for HTO)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Control (for N‐HTO)
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Overall (all patients)
Number of subjects: 141
Study: 34533197

Group type: EXPERIMENTAL
Intervention: Immediate ART initiation
Number of subjects: 2056

Group type: COMPARATOR
Intervention: Deferred ART initiation
Number of subjects: 2056
Study: 32402732

Group type: EXPERIMENTAL
Intervention: Liposomal bupivacaine (LB) TAP block
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Regular bupivacaine (RB) TAP block
Number of subjects: 219

Group type: COMPARATOR
Intervention: No TAP block
Number of subjects: 219
Study: 33817998

Group type: EXPERIMENTAL
Intervention: Neuronavigated robotic TMS mapping of bilateral motor cortex
Number of subjects: 24
Study: 36099704

Group type: EXPERIMENTAL
Intervention: Dance group (n = 17)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (n = 19)
Number of subjects: 72
Study: 34327798

Group type: EXPERIMENTAL
Intervention: Oral simvastatin
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 36296930

Group type: EXPERIMENTAL
Intervention: Group cognitive behavioral therapy (CBT)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Group interpersonal psychotherapy (IPT)
Number of subjects: 40
Study: 34551104

Group type: EXPERIMENTAL
Intervention: Low-dose vaccine
Number of subjects: 430

Group type: EXPERIMENTAL
Intervention: Middle-dose vaccine
Number of subjects: 430

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 430

Group type: EXPERIMENTAL
Intervention: Ad5-vectored COVID-19 vaccine (single dose in children and adolescents)
Number of subjects: 430

Group type: EXPERIMENTAL
Intervention: Ad5-vectored COVID-19 vaccine (two doses in adults)
Number of subjects: 430

Group type: EXPERIMENTAL
Intervention: Homologous prime-boost vaccination
Number of subjects: 430
Study: 36085612

Group type: EXPERIMENTAL
Intervention: High group (engaged in psychological processing of CDT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low group (possibly ignoring the appearance of CDT)
Number of subjects: 0
Study: 32696905

Group type: COMPARATOR
Intervention: Etching time of 15 seconds (recommended by manufacturer)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Etching time of 7 seconds (reduced)
Number of subjects: 62
Study: 34287975

Group type: EXPERIMENTAL
Intervention: Fractional RF treatment with 1.0‐mm long × 0.15‐mm diameter ultrathin electrode tips
Number of subjects: 9
Study: 32964771

Group type: EXPERIMENTAL
Intervention: Executive Function Training (EFT)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Waitlist group (Control)
Number of subjects: 96
Study: 32234355

Group type: EXPERIMENTAL
Intervention: PowerPoint-style educational intervention with grade-conscious written material and visual graphics
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: PowerPoint-style educational intervention
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 52
Study: 34280545

Group type: EXPERIMENTAL
Intervention: Intensive glycemic control
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard glycemic control
Number of subjects: 0
Study: 33865382

Group type: EXPERIMENTAL
Intervention: Social support intervention consisting of the electronic Social Network Assessment Program and Caregiver Navigation (8-week duration)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 0
Study: 32680773

Group type: EXPERIMENTAL
Intervention: MRKAd5/HIV‐1
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32844454

Group type: EXPERIMENTAL
Intervention: Lanolin-containing test creams applied twice daily for 4 weeks on arms with irritant dermatitis
Number of subjects: 26

Group type: COMPARATOR
Intervention: Lanolin-free cream base applied twice daily for 4 weeks on arms with irritant dermatitis
Number of subjects: 26
Study: 35276700

Group type: EXPERIMENTAL
Intervention: Graded exposure treatment (GET)
Number of subjects: 27
Study: 33564980

Group type: EXPERIMENTAL
Intervention: Self-reported 3-month anal intercourse occurrence
Number of subjects: 407

Group type: EXPERIMENTAL
Intervention: Self-reported frequency of anal intercourse
Number of subjects: 407

Group type: EXPERIMENTAL
Intervention: Odds of discordance associated with dyadic employment and CCS differences
Number of subjects: 407

Group type: EXPERIMENTAL
Intervention: Mean relative difference in frequency reports among discordant couples
Number of subjects: 407

Group type: EXPERIMENTAL
Intervention: Relative differences between partners' reported AI frequencies
Number of subjects: 407
Study: 36379691

Group type: EXPERIMENTAL
Intervention: Online video intervention guided by the extended theory of planned behavior
Number of subjects: 692

Group type: COMPARATOR
Intervention: Regular short reminder messages (Control)
Number of subjects: 692
Study: 34051122

Group type: EXPERIMENTAL
Intervention: Tapentadol (50 mg twice daily)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Oxycodone (10 mg twice daily)
Number of subjects: 21
Study: 35643018

Group type: EXPERIMENTAL
Intervention: Mobile health intervention (mobile applications, smartwatches, smartphone-based short text messages, and telephone counselling)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Short text messages and telephone counselling (control group)
Number of subjects: 43
Study: 34053490

Group type: EXPERIMENTAL
Intervention: High frequency oscillatory ventilation (HFOV)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Conventional mechanical ventilation (CMV)
Number of subjects: 28
Study: 36087564

Group type: EXPERIMENTAL
Intervention: Approach bias modification (ApBM)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Sham training (Control)
Number of subjects: 300
Study: 33444780

Group type: EXPERIMENTAL
Intervention: BASE programme (remotely supervised exercise programme)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Optimised adherence treatment (post-programme)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Usual adherence (post-programme)
Number of subjects: 72
Study: 35993480

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Sildenafil (50 mg)
Number of subjects: 32
Study: 32538115

Group type: EXPERIMENTAL
Intervention: Paclitaxel-coated balloon (group II)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Plain old balloon (group I)
Number of subjects: 60
Study: 36251383

Group type: EXPERIMENTAL
Intervention: Caffeine supplementation (6 mg·kg ‐1 body weight)
Number of subjects: 13
Study: 34037271

Group type: EXPERIMENTAL
Intervention: RO7062931 at 3.0 mg/kg every week (QW)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: RO7062931 at 0.5, 1.5, or 3.0 mg/kg every month for a total of 2 doses
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: RO7062931 at 3.0 mg/kg every 2 weeks, 3.0 mg/kg every week (QW), or 4.0 mg/kg QW
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study: 32327444

Group type: EXPERIMENTAL
Intervention: High-GI test meal (TM) consumed at dinner
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Low-GI test meal (TM) consumed at dinner
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: High-GI test meal (TM)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Low-GI test meal (TM)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Test meals (TM) consumed at dinner
Number of subjects: 34
Study: 36027721

Group type: EXPERIMENTAL
Intervention: idursulfase-IT 10 mg
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: idursulfase-IT
Number of subjects: 49

Group type: COMPARATOR
Intervention: no idursulfase-IT
Number of subjects: 49
Study: 33811746

Group type: EXPERIMENTAL
Intervention: First-line platinum-based chemotherapy (carboplatin/paclitaxel)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Good responders (GR)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Poor responders (PR)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Gene expression analysis by NanoString
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Tumor immune cell infiltration
Number of subjects: 39
Study: 33288404

Group type: EXPERIMENTAL
Intervention: 20% Mannitol
Number of subjects: 40

Group type: COMPARATOR
Intervention: 0.9% normal saline
Number of subjects: 40
Study: 35971156

Group type: EXPERIMENTAL
Intervention: Behavioural economics-informed SMS and voice reminder messages
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard SMS message
Number of subjects: 0
Study: 33551138

Group type: EXPERIMENTAL
Intervention: Tribochemical silica airborne‐particle abrasion (Tbc)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Tribochemical silica airborne‐particle abrasion + plasma treated (Tbc_NTP)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (untreated)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Nonthermal plasma (NTP) treated
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Abraded with a coarse‐grit diamond rotary instrument (Ab)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Abraded + plasma treated (Ab_NTP)
Number of subjects: 120
Study: 32150263

Group type: EXPERIMENTAL
Intervention: D0 rituximab infusion (500 mg)
Number of subjects: 161

Group type: COMPARATOR
Intervention: D0+D14 rituximab infusion (500 mg)
Number of subjects: 161
Study: 35144885

Group type: EXPERIMENTAL
Intervention: Oral trimethoprim-sulfamethoxazole, twice daily for 10 days postoperatively
Number of subjects: 93

Group type: COMPARATOR
Intervention: Placebo, twice daily for 10 days postoperatively
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Oral trimethoprim-sulfamethoxazole
Number of subjects: 93

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study: 34113593

Group type: EXPERIMENTAL
Intervention: 1-month mixed exercise training program supervised at the hospital, followed by 2 months in a community-based relay in a health-sport structure, combined with therapeutic patient education sessions
Number of subjects: 330

Group type: COMPARATOR
Intervention: Therapeutic patient education sessions
Number of subjects: 330
Study: 36378832

Group type: EXPERIMENTAL
Intervention: Group hypnosis
Number of subjects: 64
Study: 36198449

Group type: EXPERIMENTAL
Intervention: aLiFE or eLiFE (six-month trainer-supported)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (written PA advice)
Number of subjects: 120
Study: 33002436

Group type: EXPERIMENTAL
Intervention: Atezolizumab (1200 mg) plus trastuzumab emtansine (3.6 mg/kg)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Placebo plus trastuzumab emtansine (3.6 mg/kg)
Number of subjects: 202
Study: 34658725

Group type: EXPERIMENTAL
Intervention: Target-controlled infusion (TCI) of propofol
Number of subjects: 164

Group type: COMPARATOR
Intervention: Intermittent bolus application of propofol
Number of subjects: 164
Study: 37507795

Group type: EXPERIMENTAL
Intervention: Gamma3 cephalomedullary nailing
Number of subjects: 0

Group type: COMPARATOR
Intervention: IT cephalomedullary nailing
Number of subjects: 0
Study: 33961058

Group type: EXPERIMENTAL
Intervention: Restrictive fluid management
Number of subjects: 100

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 100
Study: 32320373

Group type: EXPERIMENTAL
Intervention: Genomic prediction using trait-related markers
Number of subjects: 509

Group type: EXPERIMENTAL
Intervention: GWAS identified SNPs associated with FER resistance
Number of subjects: 509

Group type: EXPERIMENTAL
Intervention: Bulked sample analysis (BSA)
Number of subjects: 509

Group type: EXPERIMENTAL
Intervention: Ear rot evaluation using artificial inoculation
Number of subjects: 509
Study: 32810553

Group type: EXPERIMENTAL
Intervention: Nivolumab
Number of subjects: 189

Group type: COMPARATOR
Intervention: Regorafenib
Number of subjects: 189

Group type: COMPARATOR
Intervention: Best supportive care (BSC)/placebo
Number of subjects: 189
Study: 32540410

Group type: EXPERIMENTAL
Intervention: Metabolic syndrome (MetS)
Number of subjects: 6430
Study: 36149321

Group type: EXPERIMENTAL
Intervention: Miconazole buccal tablets (MBT) plus placebo
Number of subjects: 431

Group type: COMPARATOR
Intervention: Itraconazole capsules plus placebo
Number of subjects: 431
Study: 35840067

Group type: EXPERIMENTAL
Intervention: Amniotic suspension allograft (ASA)
Number of subjects: 95
Study: 33962356

Group type: EXPERIMENTAL
Intervention: Real-world efficacy data from DAMMED
Number of subjects: 4156

Group type: COMPARATOR
Intervention: Published randomized clinical trial data
Number of subjects: 4156
Study: 32989067

Group type: EXPERIMENTAL
Intervention: Low-intensity organizational change intervention with in-person education and remote support from peer mentors and a physician informaticist.
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Low-intensity organizational change intervention.
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control practices (no specific intervention mentioned).
Number of subjects: 32
Study: 35832800

Group type: EXPERIMENTAL
Intervention: Dynamic low-temperature thermoplastic plate fixation and routine rehabilitation (Group B)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Plaster fixation and routine rehabilitation (Group A)
Number of subjects: 50
Study: 34156335

Group type: EXPERIMENTAL
Intervention: Intradialytic exercise training plus usual-care maintenance haemodialysis
Number of subjects: 379

Group type: COMPARATOR
Intervention: Usual-care maintenance haemodialysis
Number of subjects: 379

Group type: EXPERIMENTAL
Intervention: Intradialytic exercise training
Number of subjects: 379
Study: 36308858

Group type: EXPERIMENTAL
Intervention: Negative mood exposure
Number of subjects: 40

Group type: COMPARATOR
Intervention: Neutral mood exposure
Number of subjects: 40
Study: 33284166

Group type: EXPERIMENTAL
Intervention: Transplantation group
Number of subjects: 10646

Group type: COMPARATOR
Intervention: Awaiting transplantation group
Number of subjects: 10646
Study: 32118694

Group type: EXPERIMENTAL
Intervention: Parental resilience measured using the Connor-Davidson Resilience Scale at the time of consent
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: Patient-Reported Outcome Measurement Information System Short Forms 8a for Depression and Anxiety
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: Impact of Event Scale-Revised for posttraumatic stress
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: Pediatric Family Satisfaction-ICU 24 for parental satisfaction
Number of subjects: 232
Study: 35051670

Group type: EXPERIMENTAL
Intervention: Sleep study screening with autoregulated positive airway therapy
Number of subjects: 193

Group type: COMPARATOR
Intervention: Control group (standard obstetrical care)
Number of subjects: 193
Study: 33492018

Group type: EXPERIMENTAL
Intervention: Community-based care group (ART Co-op)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard of care (clinic-based care)
Number of subjects: 0
Study: 36752451

Group type: EXPERIMENTAL
Intervention: RF wire
Number of subjects: 75

Group type: COMPARATOR
Intervention: RF needle
Number of subjects: 75
Study: 33524283

Group type: EXPERIMENTAL
Intervention: Annual mammography screening
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 35188812

Group type: EXPERIMENTAL
Intervention: Anatomic technique
Number of subjects: 18

Group type: COMPARATOR
Intervention: Docking technique
Number of subjects: 18
Study: 32889556

Group type: EXPERIMENTAL
Intervention: Single-tunnel (ST) MPFL reconstruction
Number of subjects: 80

Group type: COMPARATOR
Intervention: Double-tunnel (DT) MPFL reconstruction
Number of subjects: 80
Study: 32543155

Group type: EXPERIMENTAL
Intervention: Biofeedback combined with task-oriented training
Number of subjects: 66
Study: 34520419

Group type: EXPERIMENTAL
Intervention: VR group with access to an immersive commercially available VR learning module
Number of subjects: 22

Group type: COMPARATOR
Intervention: Guide group with access to manufacturer's technique guide and surgical video
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: VR group
Number of subjects: 22

Group type: COMPARATOR
Intervention: Guide group
Number of subjects: 22
Study: 35406010

Group type: EXPERIMENTAL
Intervention: Vitamin D (1200 IU/day) + DHA (500 mg)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Vitamin D (1200 IU/day) + wheat germ oil
Number of subjects: 73
Study: 34620658

Group type: EXPERIMENTAL
Intervention: Bevacizumab-800CW (4, 5, 10 or 25 mg)
Number of subjects: 15
Study: 32202318

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 97
Study: 36151971

Group type: EXPERIMENTAL
Intervention: Cognitive remediation intervention
Number of subjects: 53

Group type: COMPARATOR
Intervention: Usual control
Number of subjects: 53
Study: 33619202

Group type: COMPARATOR
Intervention: Immediate antibiotics alone (n=15)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Immediate antibiotics and immediate cranberry capsules for up to 7 days (n=15)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Immediate cranberry capsules and delayed antibiotics for self-initiation in case of non-improvement or worsening of symptoms (n=16)
Number of subjects: 67
Study: 34140405

Group type: EXPERIMENTAL
Intervention: Carrageenan gel
Number of subjects: 255

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 255
Study: 34564057

Group type: EXPERIMENTAL
Intervention: Methylphenidate for 4 weeks
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 33177355

Group type: EXPERIMENTAL
Intervention: Laparoscopic Complete Mesocolic Excision (CME)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional right-sided colonic resection (NCME)
Number of subjects: 0
Study: 32116309

Group type: EXPERIMENTAL
Intervention: Computerized Functional Skills Training (CFST)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Combined Cognitive Training (CCT) plus CFST
Number of subjects: 95
Study: 35140146

Group type: EXPERIMENTAL
Intervention: Multidisciplinary team intervention (primary care pharmacist, family doctor, nurse) conducting multidimensional reviews and clinical interviews
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual clinical practice (control group)
Number of subjects: 0
Study: 34611435

Group type: EXPERIMENTAL
Intervention: Erector spinae plane block (ESPB)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Thoracic epidural anaesthesia (TEA)
Number of subjects: 300
Study: 35413787

Group type: EXPERIMENTAL
Intervention: i-gel
Number of subjects: 80

Group type: COMPARATOR
Intervention: LMA Protector
Number of subjects: 80
Study: 34291590

Group type: EXPERIMENTAL
Intervention: Rivastigmine (3–6 mg twice a day)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Rivastigmine
Number of subjects: 91
Study: 35584331

Group type: EXPERIMENTAL
Intervention: 10% NaOCl solution (deproteinization)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (acid etching with 37% phosphoric acid + placebo solution + Adper Single Bond 2/3M Oral Care + Filtek Z350/3M Oral Care)
Number of subjects: 30
Study: 33611826

Group type: EXPERIMENTAL
Intervention: wet silver-containing dressings (n = 28)
Number of subjects: 58

Group type: COMPARATOR
Intervention: wet to dry povidone-iodine dressings (n = 30)
Number of subjects: 58
Study: 35220503

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy (FOLFOX or CAPOX)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard chemoradiation
Number of subjects: 0
Study: 35641662

Group type: EXPERIMENTAL
Intervention: Pirfenidone (2403 mg/day)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Pirfenidone
Number of subjects: 22
Study: 32603714

Group type: EXPERIMENTAL
Intervention: Evening long‐acting bronchodilation (aclidinium bromide/formoterol fumarate dihydrate: 400/12 μg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Evening long‐acting bronchodilator (aclidinium bromide/formoterol fumarate dihydrate: 400/12 μg)
Number of subjects: 20
Study: 32429917

Group type: EXPERIMENTAL
Intervention: Healthy food nudges (e.g., product placement or promotion)
Number of subjects: 1485

Group type: EXPERIMENTAL
Intervention: Nudges and pricing strategies (taxing unhealthy foods and subsidizing healthy foods)
Number of subjects: 1485

Group type: EXPERIMENTAL
Intervention: Mobile PA app
Number of subjects: 1485

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 1485
Study: 35170079

Group type: EXPERIMENTAL
Intervention: Confusion Assessment Method (CAM)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Consensus panel diagnosis
Number of subjects: 200
Study: 34034821

Group type: EXPERIMENTAL
Intervention: Rapid Intervention (RI) group - given an appointment at the clinic within 2 days and accompanied to their first appointment.
Number of subjects: 106

Group type: COMPARATOR
Intervention: Delayed Intervention (DI) group - given contact information for a nearby addiction medicine clinic.
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Rapid Intervention (RI) group
Number of subjects: 106

Group type: COMPARATOR
Intervention: Delayed Intervention (DI) group
Number of subjects: 106